Predicting bacteraemia or rapid identification of the causative pathogen in community acquired pneumonia: where should the priority lie? Source: Eur Respir J 2016; 48: 619-622 Year: 2016
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosis Source: Eur Respir J 2015; 45: 1353-1363 Year: 2015
Risk factors for immunosuppression in hospitalized patients coming from the community with pneumonia: a worldwide perspective Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018
Healthcare-associated pneumonia among hospitalized patients. Is it really different from community acquired pneumonia? Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012
Is health care-associated pneumonia itself a predisposing factor for multi-drug resistant organisms? Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019
How do I control transmission of MDR organisms in and out the ICU? Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies Year: 2013
Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013
Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017
A worldwide perspective of nursing home pneumonia beside community acquired pneumonia Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011
Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013
Imaging patterns of bacterial community acquired pneumonia in moderately immunocompromised patients Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009
Community acquired pneumonia in elderly people: aetiology and antimicrobial drug susceptibility Source: Eur Respir J 2004; 24: Suppl. 48, 414s Year: 2004
Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology Source: Eur Respir J, 53 (3) 1802191; 10.1183/13993003.02191-2018 Year: 2019
Structure of the basic pathogens of bacterial bronchitis and pneumonia in hospitalized patients in Belarus Source: Eur Respir J 2006; 28: Suppl. 50, 4s Year: 2006
The general evaluation of elderly patients with community acquired pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004
The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006
A retrospective survival analysis of nursing and healthcare associated pneumonia in patients with resistant pathogens Source: International Congress 2018 – Improving the outcomes of community-acquired pneumonia Year: 2018
Antibiotic usage analysis of the community-acquired pneumonia at young patients from different social groups Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003